FFCM »

Crispr Therapeutics shares owned by FFCM

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by FFCM from 13F filings

Historical chart of FFCM investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by FFCM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by FFCM

Quarter filed Position value Share count Share price at filing
2022-09-30 $1.6M 25k 65.35

More positions owned by FFCM

SPDR S&P Technology Select Sector ETF Etf (XLK)
Health Care Select Sector SPDR ETF Etf (XLV)
Financial Select Sector SPDR ETF Etf (XLF)
SPDR S&P Energy Select Sector ETF Etf (XLE)
Communication Services Select Sector SPDR Fund Etf (XLC)
SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Etf (BIL)
Materials Select Sector SPDR ETF Etf (XLB)
Industrial Select Sector SPDR ETF Etf (XLI)
SPDR S&P Consumer Discretionary Select Sector ETF Etf (XLY)
Consumer Staples Select Sector SPDR ETF Etf (XLP)
Real Estate Select Sector SPDR ETF Etf (XLRE)
Utilities Select Sector SPDR ETF Etf (XLU)
Hello Group CCB (Principal)
Pinduoduo CCB (Principal)
Wayfair CCB (Principal)

View all positions for FFCM

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics